The Latest
-
Trump pauses most reciprocal tariffs, hikes China’s further
The U.S. will now charge a 125% duty on imports from China, while most other countries will be subject to a 10% rate for 90 days.
-
Kandu Health merges with BCI company Neurolutions
The merger brings together Neurolutions’ brain computer interface technology and Kandu Health’s telehealth services to try to improve stroke care.
-
Trump says ‘major’ tariffs coming on pharmaceuticals
Shares in many large drugmakers fell Wednesday on the president’s threat, which could further challenge an already battered sector.
-
Trump’s tariffs: Tracking the status of international trade actions
The U.S. has rolled out a deluge of tariffs, sparking responses from trading partners. Here’s where each tariff — threatened or realized — currently stands.
-
Trump rejects Biden administration plan to let Medicare cover obesity drugs
The decision is a setback for GLP-1 drugmakers, though it’s not entirely surprising given the Trump administration’s focus on curbing government spending.
-
J&J starts IVL trial in ‘difficult-to-cross’ coronary arteries
The device is differentiated from other Shockwave products, and rival catheters from Abbott and Boston Scientific, because it emits waves from its tip.
-
RFK Jr. won’t appear before Senate panel this week
HELP committee chair Bill Cassidy, R-La., had invited Kennedy to testify April 10 on the sweeping layoffs of federal health workers Kennedy ordered last month. A hearing could still take place later.
-
Trump tariffs
China probes US-made CT tubes after Trump hikes tariffs
The investigation indicates that China will likely favor local medtech companies over foreign competition amid international economic tensions, a J.P. Morgan analyst said.
Updated April 9, 2025 -
Trump tariffs
Trump threatens 50% tariff on China if retaliatory duties stay
The president said China has until Tuesday to back off from its plan for 34% tariffs on U.S. imports.
-
Trump tariffs
A ‘wobbly’ moment in business: Manufacturers face life under Trump’s tariffs
Companies are pushing to be more agile and flexible as the Trump administration’s baseline 10% tariff takes effect, but challenges loom ahead.
-
Labcorp launches blood test to accelerate Alzheimer’s diagnosis
Manufacturers of Alzheimer’s disease drugs have identified blood tests as a way to accelerate diagnosis and treatment.
-
Trump tariffs
Tariffs send healthcare industry into ‘unchartered waters’
Provider groups and health systems warn tariffs will test healthcare’s fragile supply chain. Wall Street, meanwhile, said medtech businesses will face pressure, particularly diabetes tech firms.
-
Enovis appoints Damien McDonald as CEO
McDonald, who is set to start as CEO on May 12, is joining a business that has expanded quickly in the orthopedic reconstruction sector.
-
Trump tariffs
AdvaMed repeats call for tariff exemption as new levies threaten healthcare supply chain
Lobby groups like AdvaMed and the American Hospital Association have so far failed to get medical devices and critical supplies carved out from the Trump administration’s tariffs.
-
Trump tariffs
China readies 34% tariff on US imports starting April 10
The country’s retaliation against President Donald Trump’s trade policies builds upon previously announced duties.
-
Dr. Oz confirmed to lead CMS
Dr. Mehmet Oz, a physician and TV personality, will lead the agency during a turbulent time for federal health programs as the HHS lays off thousands of staffers and Republicans float potential cuts to Medicaid.
Updated April 4, 2025 -
HHS overhaul
‘Just goodbyes and crying’: CDRH hit in HHS mass layoffs
Teams working on communications and policy were cut from the agency on Tuesday, according to multiple FDA workers interviewed by MedTech Dive.
-
CMR Surgical secures $200M for US robot rollout
Launching Versius in the U.S. is a top priority for CMR, which claims the system is the second most adopted soft tissue robot globally.
-
Trump tariffs
Trump installs 10% baseline tariff, country-specific duties
The president said he will levy import taxes on China, Japan and others equal to half of what they charge the U.S. based on White House calculations.
-
Boston Scientific’s Farapulse matches Medtronic cryoablation in trial
Atrial tachyarrhythmia recurred in 39 patients treated with Boston Scientific’s Farapulse PFA device, while 53 people had recurrence in the Medtronic cryoablation group.
-
Eargo, Hearx merge into one OTC hearing aid firm, receive $100M boost
Hearx, the maker of Lexie hearing aids, and Eargo competed for the OTC hearing aid market created by the FDA in 2022.
-
3 takeaways from ACC 2025
Medtronic, Abbott and Boston Scientific had updates on their devices used in heart valve disease treatment at the event.